Which Patients With Rheumatoid Arthritis Will Start Biologics, How Soon, and Why

For patients newly diagnosed with rheumatoid arthritis (RA), rapid initiation of 1 or more disease-modifying antirheumatic drugs (DMARDs), usually a conventional synthetic DMARD (csDMARD) such as methotrexate, is now regarded as the standard of care.1 However, the threshold for initiating more…

Read the full article here

Related Articles